Comparing the outcomes and side effects of adjuvant chemotherapy with and without ginger in ovarian cancer patients
Phase 3
- Conditions
- ovarian cancer.Malignant neoplasm of ovary
- Registration Number
- IRCT2014031510901N4
- Lead Sponsor
- vice chancellor of research,Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Encloses Criteria: women with ovarian cancer who had cytoreductive surgery; Wilting to participate in study
Exclusion criteria: Sensitivity to ginger ; history of previous chemotherapy; history of gynecological cancer; using vit E or omega3; Intolerances to chemotherapy
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The results of the CT scan of the abdomen and pelvis. Timepoint: Intervals during treatment and after treatment every 3 months for one year. Method of measurement: CT scan of the abdomen and pelvis.;CA125 results in the groups receiving platinum and paclitaxel. Timepoint: Intervals during treatment and after treatment every 3 months for one year. Method of measurement: Blood tests.;Side effects. Timepoint: During treatment. Method of measurement: Questionnaire.
- Secondary Outcome Measures
Name Time Method